Literature DB >> 6191220

Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity.

G N Rogers, J C Paulson, R S Daniels, J J Skehel, I A Wilson, D C Wiley.   

Abstract

The haemagglutinin (HA) glycoproteins of influenza virus membranes are responsible for binding viruses to cells by interacting with membrane receptor molecules which contain sialic acid (for review see ref. 1). This interaction is known to vary in detailed specificity for different influenza viruses (see, for example, refs 2-4) and we have attempted to identify the sialic acid binding site of the haemagglutinin by comparing the amino acid sequences of haemagglutinins with different binding specificities. We present here evidence that haemagglutinins which differ in recognizing either NeuAc alpha 2 leads to 3Gal- or NeuAc alpha 2 leads to 6Gal- linkages in glycoproteins also differ at amino acid 226 of HA1. This residue is located in a pocket on the distal tip of the molecule, an area previously proposed from considerations of the three-dimensional structure of the haemagglutinin to be involved in receptor binding.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191220     DOI: 10.1038/304076a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  292 in total

Review 1.  The evolution of human influenza viruses.

Authors:  A J Hay; V Gregory; A R Douglas; Y P Lin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

2.  Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals.

Authors:  M Matrosovich; A Tuzikov; N Bovin; A Gambaryan; A Klimov; M R Castrucci; I Donatelli; Y Kawaoka
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 3.  The contribution of animal models to the understanding of the host range and virulence of influenza A viruses.

Authors:  Christopher D O'Donnell; Kanta Subbarao
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

4.  Restrictions to the adaptation of influenza a virus h5 hemagglutinin to the human host.

Authors:  Ruth Harvey; Andrew C R Martin; Maria Zambon; Wendy S Barclay
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

5.  Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses.

Authors:  Wen-Chun Liu; Shih-Chang Lin; Yen-Ling Yu; Ching-Liang Chu; Suh-Chin Wu
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

6.  Glycosylation at 158N of the hemagglutinin protein and receptor binding specificity synergistically affect the antigenicity and immunogenicity of a live attenuated H5N1 A/Vietnam/1203/2004 vaccine virus in ferrets.

Authors:  Weijia Wang; Bin Lu; Helen Zhou; Amorsolo L Suguitan; Xing Cheng; Kanta Subbarao; George Kemble; Hong Jin
Journal:  J Virol       Date:  2010-04-28       Impact factor: 5.103

7.  Residue Y161 of influenza virus hemagglutinin is involved in viral recognition of sialylated complexes from different hosts.

Authors:  Minxiu Wang; Donna M Tscherne; Christopher McCullough; Michael Caffrey; Adolfo García-Sastre; Lijun Rong
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

8.  Critical role of airway macrophages in modulating disease severity during influenza virus infection of mice.

Authors:  Michelle D Tate; Danielle L Pickett; Nico van Rooijen; Andrew G Brooks; Patrick C Reading
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

Review 9.  Structural insights into the design of novel anti-influenza therapies.

Authors:  Nicholas C Wu; Ian A Wilson
Journal:  Nat Struct Mol Biol       Date:  2018-02-02       Impact factor: 15.369

10.  A human-infecting H10N8 influenza virus retains a strong preference for avian-type receptors.

Authors:  Heng Zhang; Robert P de Vries; Netanel Tzarum; Xueyong Zhu; Wenli Yu; Ryan McBride; James C Paulson; Ian A Wilson
Journal:  Cell Host Microbe       Date:  2015-03-11       Impact factor: 21.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.